The PrEPWatch Resource Database offers a wide range of material on the status of PrEP as an option for biomedical HIV prevention around the world. Search this database to find step-by-step guidance for rolling out PrEP, summaries of the research to date on safety, efficacy and implementation, tools to assist planning and roll out, country updates on PrEP policy and access, and lessons learned from those efforts.
Showing results 41 - 49 of 49
FDA approves second drug to prevent HIV infection as part of ongoing efforts to end the HIV epidemic
This article announces the U.S. Food and Drug Administration's approval of Descovy in at-risk adults and adolescents for HIV pre-exposure prophylaxis (PrEP) to reduce the risk of HIV infection from sex, excluding those who have receptive vaginal sex.
Descovy for PrEP – FDA Supplemental Approval
This letter from the US Food and Drug Administration outlines supplemental approval granted to Descovy, an oral PrEP medication.
PrEP Demand Generation Toolkit
A resource guide for community organizations to generate demand for pre-exposure prophylaxis (PrEP) among key population communities. More information available here.
Community/Advocacy, Demand Creation/Marketing
What’s the 2+1+1? Event-driven oral pre-exposure prophylaxis to prevent HIV for men who have sex with men: Update to WHO’s recommendation on oral PrEP
Based on the available evidence published so far, this technical brief updates the current WHO recommendation on oral PrEP to include an option of event-driven dosing for men who have sex with men.
Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations (2014)
In 2014, WHO updated its Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection to include a recommendation of PrEP as a prevention option for gay men and other men who have sex with men; this document also recognizes the utility of PrEP for serodiscordant couples in some contexts.
Community/Advocacy, Demand Creation/Marketing, Normative Guidance/Policies
Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection — Second edition
In June 2016, WHO released guidelines on the diagnosis of HIV infection, the use of ARVs for treating and preventing HIV infection and the care of people living with HIV. They are structured along the continuum of HIV testing, prevention, treatment and care. This edition updates the 2013 consolidated guidelines on the use of antiretroviral…
Monitoring & Evaluation, Normative Guidance/Policies, Research
Kenya PrEP Communications Landscape Analysis
McCann Global Health conducted this situation analysis of all available communication on HIV prevention and PrEP for target audiences in Kenya. This analysis was used to identify gaps in market intelligence that should be further explored. The following presentation outlines the findings.
Key Population Activist Toolkit: PrEP
A toolkit to promote community-led solutions to create demand for PrEP from key populations. Produced by the International Treatment Preparedness Coalition.
PrEP Communications Accelerator
The PrEP Communications Accelerator is a free interactive, digital resource that builds sample communications strategy to create demand for PrEP among target audiences in sub-Saharan Africa. Both easy-to-use and information-rich, the Accelerator offers tested guidance throughout the lifecycle of a PrEP communications campaign and can be applicable across all PrEP formulations.
Community/Advocacy, Demand Creation/Marketing, Research